Grants and Contributions:

Back to search

Title:

Development and Validation of a Simple Blood Test for Colorectal Cancer

Agreement Number:

937606

Agreement Value:

$254,375.00

Agreement Date:

Nov 4, 2019 - Mar 25, 2022

Description:

Colorectal cancer (CRC) is one of the most preventable cancers with early detection, but remains the second leading cause of cancer death in Canada and the United States. Given the high impact of CRC, there is an urgent need for a more convenient, more accurate and cost-effective screening test to triage patients for more intensive procedures such as colonoscopy. This would improve patient compliance and clinical outcomes with a significant impact on population health and health care costs. The proposed project aims to clinically validate a simple blood test developed by VastCon for CRC screening. A successful project outcome will allow the company to commercialize their innovation.

Organization:

National Research Council Canada

Expected Results:

The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization

Location:

Winnipeg, Manitoba, CA R3Y 0A2

Reference Number:

172-2019-2020-Q3-937606

Agreement Type:

Contribution

Report Type:

Grants and Contributions

Recipient Business Number:

810234633

Recipient Type:

For-profit organization

Additional Information:

This agreement has been amended 2 time(s). The end date of this agreements has been modified by 364 days. The total amended value is -40,625 dollars.

Amendment Date

Mar 23, 2021

Recipient's Legal Name:

Vastcon Inc.

Federal Riding Name:

Winnipeg South

Federal Riding Number:

46013

Program:

Industrial Research Assistance Program – Contributions to Firms

Program Purpose:

Coverage:

IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.

NAICS Code:

33911

Amendments:

See Amendments